Hormonal Contraceptive Labeling: FDA Issues Draft Guidance
By Michael Mezher -
Published 03 January 2018
The US Food and Drug Administration (FDA) on Tuesday issued new draft guidance providing labeling recommendations for hormonal contraceptives in line with requirements from the agency's 2006 physician labeling rule (PLR) and 2014 pregnancy and lactation labeling rule (PLLR).
Categories: News, US, FDA, Drugs, Labeling
Tags: Combined Hormonal Contraceptives, CHC, Oral Contraceptives, Draft Guidance